1Doern GV, Heilmann KP, Huynh HK, et al. Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999 - 2000, including a comparison of resistance rates since 1994 - 1995. Antimicrob Agents Chemother, 2001,45 (6) : 1721 - 1729.
2Noquchi N ,Tano J, Nasu Y,et al. Antimicrobial susceptibilities and distribution of resistance genes for beta - lactams and macrolides in Streptococcus pneumoniae isolated between 2002 and 2004 in Tokyo. Int J Antimicrob Agents,2007,29( 1 ) :26 -33.
3Thornsberry C, Sahm DF, Kelly LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States:results from the TRUST Surveillance Program, 1999 - 2000. Clin Infect Dis,2002,34( Suppl1) : S4 - S16.
4Fluit AC, Wielders CLC, Verhoef J, et al. Epidemiology and Susceptibility of 3051 Staphylococcus aureus Isolates from 25 University Hospitals Participating in the European Sentry Study. J Clin Mierobiol,2001, 39(10) :3727 -3732.
5Nijssen S,Florijn A , Bonten MJ, et al. Beta-lactam susceptibilities and prevalence of ESBL-produeing isolates among more than 5000 European Enterobacteriaceae isolates. Int J Antimicrob Agents,2004,24 (6) : 585 -591.
8Karlowsky JA, Draghi DC, Jones ME,et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother,2003,47 : 1681 - 1688.
